David Golde - Net Worth and Insider Trading

David Golde Net Worth

The estimated net worth of David Golde is at least $3,432 dollars as of 2024-11-10. David Golde is the Director of Enzon Pharmaceuticals Inc and owns about 40,379 shares of Enzon Pharmaceuticals Inc (ENZN) stock worth over $3,432. Details can be seen in David Golde's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Golde has not made any transactions after 2004-05-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David Golde

To

David Golde Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Golde owns 1 companies in total, including Enzon Pharmaceuticals Inc (ENZN) .

Click here to see the complete history of David Golde’s form 4 insider trades.

Insider Ownership Summary of David Golde

Ticker Comapny Transaction Date Type of Owner
ENZN Enzon Pharmaceuticals Inc 2004-05-17 director

David Golde Latest Holdings Summary

David Golde currently owns a total of 1 stock. David Golde owns 40,379 shares of Enzon Pharmaceuticals Inc (ENZN) as of May 17, 2004, with a value of $3,432.

Latest Holdings of David Golde

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENZN Enzon Pharmaceuticals Inc 2004-05-17 40,379 0.09 3,432

Holding Weightings of David Golde


David Golde Form 4 Trading Tracker

According to the SEC Form 4 filings, David Golde has made a total of 0 transactions in Enzon Pharmaceuticals Inc (ENZN) over the past 5 years. The most-recent trade in Enzon Pharmaceuticals Inc is the sale of 17,320 shares on May 17, 2004, which brought David Golde around $248,888.

Insider Trading History of David Golde

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Golde Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Golde Ownership Network

Ownership Network List of David Golde

No Data

Ownership Network Relation of David Golde

Insider Network Chart

David Golde Owned Company Details

What does Enzon Pharmaceuticals Inc do?

Who are the key executives at Enzon Pharmaceuticals Inc?

David Golde is the director of Enzon Pharmaceuticals Inc. Other key executives at Enzon Pharmaceuticals Inc include other: See Footnote 1 Family Fund Couchman , other: See explanation of responses Brian James Harper , and other: See explanation of responses Harper Asset Management Llc .

Enzon Pharmaceuticals Inc (ENZN) Insider Trades Summary

Over the past 18 months, David Golde made no insider transaction in Enzon Pharmaceuticals Inc (ENZN). Other recent insider transactions involving Enzon Pharmaceuticals Inc (ENZN) include a net purchase of 99,550 shares made by Randolph C Read ,

In summary, during the past 3 months, insiders sold 0 shares of Enzon Pharmaceuticals Inc (ENZN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzon Pharmaceuticals Inc (ENZN) were sold and 99,550 shares were bought by its insiders, resulting in a net purchase of 99,550 shares.

Enzon Pharmaceuticals Inc (ENZN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enzon Pharmaceuticals Inc Insider Transactions

No Available Data

David Golde Mailing Address

Above is the net worth, insider trading, and ownership report for David Golde. Currently GuruFocus does not have mailing address information for David Golde.